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Summary 
Staphylococcus aureus is one of the leading causes of nosocomial and community-acquired 
infections. It is a frequent colonizer of the human body, but can also lead to life-threatening 
diseases. Due to the high adaptability of S. aureus to its environment and certain antibiotics, 
treatment of S. aureus infections has become increasingly difficult.  
Antibiotic resistance can occur by several different mechanisms, thereof one is the unspecific 
export via multidrug efflux pumps as shown for AcrB in Escherichia coli. AcrB belongs to 
the resistance-nodulation-cell division (RND) family, which is conserved throughout all three 
kingdoms of life and has diverse biological functions. S. aureus possesses three 
uncharacterized RND proteins: the AcrB homologue SA2056, the MmpL-like SA2339 and 
SecDF. The aim of this project was to characterize RND proteins in S. aureus and to study 
their role in fitness, resistance and virulence. 
Deletion of sa2056 and sa2339 had no influence on growth, fitness and resistance under the 
conditions tested. However, SA2056, encoded by the gene sa2056 situated downstream of 
femX, was shown to interact with itself and with several other factors involved in cell wall 
synthesis: FemB and the penicillin binding proteins PBP1 and PBP2. FemX and FemB both 
play an important role during cell wall synthesis by catalyzing the addition of the first and last 
two glycines to the pentaglycine crossbridge, respectively. Interaction with FemB was 
confirmed by pull-down experiments. However, a sa2056 femB double mutant did not show 
any aggravation of the femB phenotype regarding β-lactam sensitivity and lysostaphin 
resistance. These results suggest an accessory role of SA2056 in the peptidoglycan synthesis 
pathway. 
The third RND protein, SecDF, is part of the Sec secretion system and was shown to enhance 
protein secretion in E. coli. Deletion of secDF had a pleiotropic effect. Growth under normal 
conditions was only slightly reduced, which was exacerbated at 15 °C as shown for E. coli 
and Bacillus subtilis secDF mutants. Susceptibility towards β-lactam and glycopeptide 
antibiotics in an S. aureus methicillin susceptible and resistant background, as well as towards 
RND substrates, was increased. The ultrastructure of secDF mutant cells displayed a partly 
impaired cell division. Furthermore, autolysis was increased. Transcription and expression 
analysis of specific virulence determinants indicated further indirect effects on important 
processes, not only secretion.  
A quantitative secretome analysis revealed an altered composition of the extracellular proteins 
in the secDF mutant with numerous Sec-dependent virulence factors decreased. The 
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diminished amounts of virulence determinants led to a significantly reduced adhesion, 
invasion and cytotoxicity of the secDF mutant in human umbilical vein endothelial cells and 
to a reduced pathogenicity using an insect infection model. Altogether, this study identified 
SecDF to be a promising therapeutic target for controlling S. aureus infections, since the 
absence of SecDF reduced both S. aureus virulence and resistance to well established 
antibiotics. 
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Zusammenfassung 
Staphylococcus aureus ist einer der häufigsten Erreger von nosokomialen und nicht-
nosokomialen Infektionen. Dieser opportunistische Erreger kann den Menschen 
asymptomatisch besiedeln, aber auch lebensbedrohliche Krankheiten hervorrufen. Die hohe 
Anpassungsfähigkeit gegenüber seiner Umwelt und gewisser Antibiotika, sowie ein breites 
Arsenal von Virulenzfaktoren tragen zum Erfolg dieses Pathogens bei. 
Die Antibiotika Resistenz kann durch verschiedene Mechanismen entstehen, ein 
Mechanismus ist der unspezifische Export durch Efflux-Pumpen, wie bei AcrB in Escherichia 
coli. AcrB gehört zur so genannten „resistance-nodulation-cell divsion“ (RND) Familie, 
welche in allen drei Reichen Archaeen, Prokaryoten und Eukaryoten vertreten ist. RND 
Proteine können unterschiedliche biologische Funktionen ausüben. S. aureus besitzt drei 
uncharakterisierte Proteine, welche aufgrund ihrer Aminosäurensequenz- und Struktur-
Homologie zur RND Familie gehören: SA2056, SA2339 und SecDF. Das Ziel dieser Arbeit 
war die Charakterisierung dieser Protein-Gruppe und ihre Auswirkung auf Fitness, Resistenz 
and Virulenz in S. aureus.  
Unter den getesteten Bedingungen, hatte die Deletion von sa2056 und sa2339 keinen Einfluss 
auf das Wachstum, die Fitness und Resistenz. Bei SA2056 konnte jedoch eine Interaktion mit 
sich selbst und anderen Faktoren, welche an der Zellwandsynthese beteiligt sind, 
nachgewiesen werden. Die Interaktion zwischen SA2056 und FemB wurde mit einem Pull-
Down Experiment bestätigt. FemB ist an der Peptidoglykan (PG)-Vorläufersynthese beteiligt. 
Eine sa2056 femB Doppelmutante zeigte jedoch keine Verstärkung des femB Phänotyps 
bezüglich seiner β-Lactam Empfindlichkeit oder Lysostaphin Resistenz. Die Resultate weisen 
auf eine eher kleine Helfer-Rolle von SA2056 in der PG-Synthese hin. 
Das dritte RND Protein SecDF ist ein Teil der wichtigen Sec Transportmaschinerie und 
steigert in E. coli den Export von Proteinen aus dem Zytoplasma. Die Deletion von secDF in 
S. aureus zeigte einen vielseitigen Effekt. Unter normalen Bedingungen war nur ein etwas 
vermindertes Wachstum sichtbar, welches sich bei 15 °C jedoch drastisch verstärkte. Einen 
ähnlichen kälteempfindlichen Phänotyp wurde bereits in E. coli und Bacillus subtilis secDF 
Mutanten nachgewiesen. Die Empfindlichkeit gegenüber β-Lactam und Glykopeptid 
Antibiotika in einem Methicillin empfindlichen und einem Methicillin resistenten Stamm 
sowie gegenüber RND-Substrate, war erhöht. Elektronenmikroskopische Aufnahmen der 
Zellen zeigte eine gestörte Zellteilung beim Fehlen von SecDF. Zudem wurde eine erhöhte 
Autolyseaktivität festgestellt. 
Zusammenfassung 
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Die Analyse der Expression und Transkription betroffener Virulenzfaktoren zeigte einen 
zusätzlichen, womöglich indirekten Effekt auf weitere Prozesse und nicht nur auf die 
Proteinsekretion. 
Eine quantitative Sekretom-Analyse der secDF Mutante zeigte ein verändertes Exoproteom 
mit einer reduzierten Menge von Sec-abhängigen Virulenzfaktoren. Dies führte zu einer 
signifikant reduzierten Adhäsion an humanen Nabelschnur-Endothelzellen (HUVECs), und 
signifikant reduzierten Invasion und Zytotoxizität. Zudem war die Virulenz der secDF 
Mutante in einem Galleria mellonella Infektions-Model signifikant reduziert. Insgesamt 
konnte diese Arbeit zeigen, dass SecDF ein sehr interessantes Zielmolekül zur Bekämpfung 
dieses Erregers ist, da nicht nur die Virulenz, sondern auch die Resistenz gegen gut etablierte 
Antibiotika reduziert ist. 
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1 Introduction 
1.1 Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive, non-motile bacterium and belongs to the family of 
micrococcaceae. Its name arises from the irregular grape like clustering of the cocci, as well 
as the yellow colouring of the colony forming units (Greek: staphyle – a bunch of grapes; 
Greek: kokkos – grain, seed; Latin: aurum – gold) (Figure 1). The cell size ranges from 0.8 to 
1 µM in diameter. The genome of S. aureus has a size of approximately 2.8 mb and consists 
of 2’592-2’748 protein-coding open reading frames (ORF) depending on strain (94). The 
highly conserved core genome consists of around 78 % and comprises mainly housekeeping 
genes, the remaining 22 % are non-essential genes and mobile genetic elements (82, 157). The 
G+C-content is low and varies around 33 % (152). The first sequenced S. aureus genomes 
N315 and Mu50 were published in 2001 (152). Up to date there are 32 published whole 
genome sequences at the National Center for Biotechnology Information (NCBI) (190) and 
there are plenty of unfinished genomic sequence data available in the High Throughput 
Genomic (HTG) GenBank Division (210). 
S. aureus colonizes the skin and mucous membrane of humans as well as several animals 
(167). About 60 % of the healthy human population is colonized intermittently, whereas 20 % 
of the population belongs to the persistent carriers (146). This is relevant since numerous 
reports point towards an association between S. aureus infections and S. aureus nasal carriage 
as a source of infection, moreover the nose is the most frequently colonized body part in 
humans (146, 290, 297, 299). S. aureus is an opportunistic pathogen that can cause a wide 
spectrum of diseases, ranging from superficial skin infections and food-poisoning to life-
threatening endocarditis, osteomyelitis, septicaemia or toxic shock syndrome. In the USA a 
national wide study of healthcare-associated infections among surgical patients revealed 
S. aureus to be the most frequently found pathogen (36 %), along with coagulase-negative 
staphylococci (17 %), Escherichia coli (10 %) and enterococci (8 %). Eleven percent of the 
S. aureus isolates were methicillin resistant S. aureus (MRSA) (241). The increasing numbers 
of nosocomial and community-acquired (CA) MRSA infections are a great problem for 
healthcare facilities (68, 160, 174, 208).  
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Figure 1. Images of S. aureus. (A) S. aureus colonies on sheep blood agar plates. (B) Scanning electron 
micrograph pictures of S. aureus. Picture was taken from (37). (C) Transmission electron micrograph of a 
separating S. aureus cell. 
 
1.1.1 Cell wall 
S. aureus is surrounded by a thick cell wall. The function of the bacterial cell wall is diverse; 
its main purpose is to protect the bacterium against the high internal osmotic pressure of 20 
atm (178) and to maintain the cell shape. Thirty to 70 % of the cell wall of Gram-positive 
bacteria consists of multiple layers of cross-linked peptidoglycan (PG) (20-40 nm) with bound 
surface proteins and wall teichoic acids (242). The disaccharide sugar structures of the PG 
consists of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), 
which are covalently linked by β-1,4 glycosidic bonds. The S. aureus stem pentapeptide, L-
alanine-D-iso-glutamine-L-lysine-D-alanine-D-alanine, branches off the carboxyl group of the 
uridine-diphosphate (UDP)-MurNAc (242). The first biosynthetic steps are accomplished by 
the enzymes MurA to MurF and the D-alanine-D-alanine ligase Ddl (Figure 2). The transferase 
MraY anchors the soluble UDP-MurNAc pentapeptide to the undecaprenyl phosphate (C55-P) 
yielding the membrane-bound intermediate lipid I (25). The lipid carrier C55-P is needed for 
the transport of the hydrophilic PG-precursor across the membrane; furthermore it is also 
involved in other biosynthetic pathways, such as the teichoic acid synthesis (65). The glycosyl 
transferase MurG catalyzes the addition of GlcNAc to the membrane linked MurNAc-
pentapeptide resulting in lipid II (288). Still at the cytoplasmic side of the membrane, the 
three non-ribosomal peptidyltransferases FemABX add five glycines to the ε-amino group of 
the L-lysine in a sequential way. The PG precursor is transported across the membrane by a 
yet unknown mechanism (26) and the pentaglycine bridge is cross-linked to the adjacent stem 
peptide connecting the L-lysine to the D-alanine, thereby cleaving off the last D-alanine. The 
final steps of the PG polymerization, the transglycosylation and the transpeptidation, are 
catalyzed by the penicillin binding proteins (PBPs). Methicillin susceptible S. aureus possess 
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four PBPs; the high-molecular weight PBPs1-3 and the low-molecular weight 
carboxypeptidase PBP4 (118). PBP1, 3 and 4 are monofunctional and exhibit transpeptidase 
activity, only PBP2 is a bifunctional enzyme with transpeptidase and transglycosylase activity 
(93, 96, 184). 
As the bacterial cell wall is important for both survival and virulence of microorganisms, it is 
an excellent target for antibiotics. The two main antibiotics of choice for treatment of 
S. aureus infections are cell wall active antibiotics: penicillinase-resistant β-lactams for 
MSSA- and vancomycin for MRSA-infections (229). 
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Figure 2. Schematic representation of the peptidoglycan biosynthesis pathway with the corresponding 
enzymes. The first steps of the PG synthesis take place in the cytoplasm. After the addition of the five depicted 
amino acids to the sugar component MurNAc, the MurNAc-pentapeptide is bound to the membrane by its 
attachment to the undecaprenyl phosphate. The second sugar moiety GlcNAc is then added to the lipid I and the 
peptidyltransferases FemABX add five glycines to the L-lysine. On the outer side of the membrane the PBPs 
catalyze the cross-linking of the stem peptides by transglycosylation and transpeptidation. A selection of cell 
wall active antibiotics is indicated in red. Adapted from (166). 
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1.1.2 Antibiotic resistance 
Penicillin was discovered by chance in 1928 by Alexander Fleming (83). S. aureus culture 
plates got accidentally contaminated by a mould, which displayed a growth inhibition zone. It 
took several years until the importance of this finding, as well as the skills to produce 
penicillin in large quantities, was realised. In the early 1940s penicillin was applied in clinical 
practice and penicillin mass-production started. Soon afterwards the first penicillin resistant 
S. aureus appeared, producing the β-lactam ring hydrolyzing enzyme penicillinase (12). 
Nowadays more than 95 % of staphylococcal isolates carry a penicillinase in North America 
(160). A second development of β-lactam resistance occurred in 1961, only one year after 
introducing the new semi-synthetic penicillinase resistant β-lactam antibiotic methicillin (133, 
234). It took over 20 years to discover the responsible gene for methicillin resistance, mecA 
(111). Since the discovery of penicillin, more antibacterial agents have been discovered and 
developed, followed by a rapid evolution of antibiotic resistant bacteria. 
Microorganisms employ three different strategies to conquer antibiotics; (i) drug modification 
or inactivation, (ii) drug target modification, (iii) enhanced efflux of drug (53). These 
alterations can be achieved, by acquiring resistance genes, by gene regulation or by 
chromosomal mutations; the spontaneous mutation frequency lies between 10-7 and 10-10. 
 
1.1.2.1 β-lactam resistance 
β-lactams have structural similarities to the D-ala2 end of the PG pentapeptide and can 
therefore bind irreversibly to the active site of the PBPs, thereby inhibiting their mode of 
action (93). This leads to reduced cross-linking, disturbance of the cell wall integrity, to cell 
stress response and eventually lysis and cell death (148). The precise mechanism is still 
unclear and is dependent on the drug concentration.  
S. aureus has two main mechanisms to become β-lactam resistant: (i) By the production of the 
penicillinase BlaZ, which is able to inactivate penicillin by hydrolyzing the β-lactam ring or 
(ii) by the acquisition of an additional PBP; PBP2a (or PBP2’). The second mechnism 
displays a broader activity, since it also confers resistance against penicillinase resistant β-
lactams. 
PBP2a is encoded chromosomally by the mecA gene and displays a lower affinity to β-lactam 
antibiotics than the intrinsic PBPs 1-4 (111, 231). Together with the remaining 
transglycosylation activity of PBP2 it completes the cross-linking of the PG in presence of β-
lactams (224). 
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mecA is located on a large mobile genetic element, the staphylococcal cassette chromosome 
mec (SCCmec) (128, 142). The SCCmec integrates at a specific integration site sequence 
(ISS) at the 3’-end of orfX. orfX has recently been described to encode a RlmH type ribosomal 
methyltransferase, which methylates the 70 S ribosomes (27). Transcription and expression of 
orfX is not disturbed by the incorporation of SCCmec. The origin of the SCCmec element still 
remains unclear, but it is proposed to derive from animal associated coagulase negative 
staphylococci (280). The International Working Group on the Classification of 
Staphylococcal Cassette Chromosome Elements (129) was established to standardize and 
simplify the classification of these mobile elements. SCCmec elements should exhibit the 
following four characteristics: (i) contain the mec gene complex including mecA, (ii) contain 
the ccr gene complex with ccrAB and/or ccrC, (iii) integrate at a specific integration site, the 
ISS and (iv) possess flanking direct repeat sequences containing the ISS. To date there are 
eleven SCCmec types, which are defined by point (i) and (ii). The size of SCCmec varies 
between 21-67 kb depending on the elements (119). Besides mecA, the mec gene complex 
comprises the entire or truncated regulatory genes mecI and mecR1 and the ccr gene complex, 
which holds the recombination and excision locus. The non-essential components of the 
resistance island are called junkyard or joining regions (J regions). They can be used for 
subtyping and are a hotspot for integration of additional resistance genes. 
Furthermore, there are borderline resistant S. aureus strains, which display a low level 
methicillin resistance without the production of PBP2a (181). The reduced susceptibility 
against penicillinase-resistant penicillins was first thought to be caused by the β-lactamase 
hyperproduction (170), but according to Montanari et al. borderline resistant strains produce, 
in addition to the penicillinase, a methicillin specific β-lactamase (methicillinase), which is 
responsible for the reduced susceptibility (164, 180). Another possibility are amino acid (aa) 
substitutions in the PBPs, which result in a modified drug reactivity (103, 188, 273). 
 
1.1.2.2 Regulation of β-lactam resistance 
Both β-lactam resistance mechanisms blaZ and mecA are regulated by a cognate two- and 
three-component system BlaR1-BlaI and MecR1-MecI-MecR2, respectively (as reviewed in 
(90)). Most studies were performed with the blaZ two-component system (TCS). 
 
Regulation of blaZ 
The blaZ regulating TCS is usually plasmid borne (102, 237, 238) and composed of the 
structural gene blaZ, the sensor transducer blaR1, as well as the repressor blaI. blaZ and 
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blaR1-blaI are divergently transcribed and have an overlapping promoter/operator region 
(Figure 3). β-lactam antibiotics induce blaZ transcription by acylation of the active-site serine 
of the exoplasmic penicillin-binding domain of BlaR1 (298), which results in a 
conformational change and autocatalytic cleavage of the sensor transducer within the 
cytoplasmic domain (302). The so far described BlaR1 autoproteolytic activity seems to occur 
also without the induction by β-lactams, as shown recently in a heterologous expression 
system in E. coli (158). Following the metalloproteolytic cleavage of the dimeric repressor 
BlaI2, which occurs directly by BlaR1 (158), BlaI is released from the promoter/operator 
region and the transcription of the blaZ and the blaR1-blaI operon is activated (302). BlaR1 is 
constantly replenished to ensure continuous cleavage of BlaI2. As soon as the β-lactam 
concentration decreases, the autoproteolytic cleavage of the sensor transducer is reduced and 
the repressor is able to dimerize and block the promoter/operator region again. 
Interestingly, an additional factor BlaR2, which is unlinked to the penicillinase plasmid, was 
proposed to be involved in blaZ regulation, but the precise function and role of BlaR2 was 
never elucidated (51). 
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Figure 3. Regulation of β-lactam resistance by the two-component system BlaR1-BlaI. During the 
uninduced state, the homodimer BlaI2 binds to the promoter/operator region of blaZ and the blaR1-blaI operon, 
preventing transcription of blaZ. After exposure to β-lactam, the antibiotic binds to the sensor domain of blaR1 
and autoproteolytic cleavage of BlaR1 is induced. This leads to the direct cleavage of BlaI2 and induction of blaZ 
and the blaR1-blaI operon. Adapted and modified from (54). 
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Regulation of mecA 
Due to strong homology, mecA regulation was originally thought to function similarly to the 
cognate blaZ TCS. But different induction kinetics of BlaR1 and MecR1 by β-lactams (172) 
and the recent finding of a third component, the anti-repressor mecR2 lying downstream of 
mecI (6), indicate subtle differences between the two systems. mecR2 is co-transcribed with 
the mecR1-mecI operon and MecR2 shows 60-64 % aa identity with the XylR repressor of the 
xylose operon of S. xylosus (6). 
The revised model is as followed: β-lactams induce the signal transduction cascade by a yet 
unknown mechanism by binding to the sensor domain of MecR1 (163). Activation leads to 
the transcription of mecA and the regulatory operon mecR1-mecI-mecR2. MecR2 supports the 
inactivation of the repressor MecI dimers by proteolytic cleavage (6). Furthermore, MecI2 
proteolysis was shown to be crucial for the optimal expression of the β-lactam resistant 
phenotype (7).  
Due to the high aa sequence identity (61 %) of MecI and BlaI (91), both repressors are able to 
bind to either promoter/operator region of mecA-mecR1-mecI and blaZ-blaR1-blaI. In contrast 
to the co-repression, cleavage of the repressor is only achieved by their cognate sensor 
transducers MecR1 and BlaR1, which have an aa sequence identity of 34 % (172, 298).  
 
1.1.2.3 Chromosomal factors influencing β-lactam resistance 
The level of β-lactam resistance does not directly correlate with the amount of PBP2a, 
moreover, it was shown that several chromosomally encoded factors influence β-lactam 
resistance (38, 110, 185). These genes were initially called factors essential for methicillin 
resistant (fem) or auxiliary (aux) factors (16, 62). The majority is directly or indirectly 
involved in cell wall metabolism. However, also genes of the stress response, of ABC 
transporters or protein kinases were found to influence methicillin resistance (16, 17, 62, 63, 
251, 300).  
 
1.1.2.4 Glycopeptide resistance 
Vancomycin is one of the most clinically relevant glycopeptides and was discovered in the 
early 1950s. Vancomycin binds to the acyl-D-alanyl-D-alanine of the pentapeptide and 
prevents transpeptidation and transglycosylation of the PG precursors, the latter due to steric 
hindrance (13, 230). Widespread use only began 30 years after it was discovered (144). This 
was primarily due to the simultaneous development of 2nd and 3rd generation β-lactam 
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antibiotics, as well as early problems with vancomycin toxicity, which was later found to be 
caused by impurities in the preparations (98). The increasing appearance of MRSA in the 
1980s led to an increased use of vancomycin as an antibiotic of last resort. First vancomycin 
resistant microorganisms were reported in Enterococcus faecium in 1986 (154) and in the 
coagulase-negative Staphylococcus haemolyticus in 1987 (248). Ten years later the first 
MRSA with reduced susceptibility to vancomycin was described in Japan (120). Two 
different vancomycin resistance strategies have evolved in the past decades, which are also 
reflected in the MIC of the isolates. The vancomycin intermediate resistant S. aureus (VISA) 
has an MIC of 4-8 µg/ml and the high-level vancomycin resistant S. aureus (VRSA) has an 
MIC of >16 µg/ml. VISA display a thickened and/or poorly cross-linked cell wall with more 
free D-alanyl-D-alanine residues that are available to bind to vancomycin. Furthermore a 
“clogging-phenomenon” was observed by vancomycin molecules trapped in the PG 
meshwork, preventing the other molecules to reach the actual site of PG biosynthesis. 
Increased cell wall thickness is achieved by decreased cell wall turn over and reduced 
autolytic activity or increased cell wall synthesis. Therefore, it is often accompanied by a high 
fitness cost and an unstable resistance phenotype, which is frequently lost when passaged 
without vancomycin. The reduced vancomycin susceptibility is a result of point mutations in 
regulatory genes (21, 56, 122, 187, 191, 247, 251). In 2002 the first high-level VRSA was 
identified with an MIC of > 32 µg/ml in the USA (39). This clinical isolate carried a 
multiresistance conjugative plasmid harbouring the vanA gene cluster mediated by transposon 
Tn1546 (296). From the same site of infection a vancomycin resistant Enterococcus faecalis 
(VRE) was isolated carrying the identical vanA gene cluster on a different conjugative 
plasmid. This suggests that one or two genetic events took place: interspecies transduction of 
the Tn1546 or conjugative transfer of the VRE plasmid, excision and integration of Tn1546 in 
another plasmid. So far, no dissemination of VRSA from person-to-person has been observed 
(257). 
To date, eight different Van phenotypes have been described in enterococci, but only the 
VanA resistance type has been observed in S. aureus (36). The VanA gene cluster consists of 
the two regulatory genes vanRS and the five resistance genes vanHAXYZ, whereof vanHAX 
are essential for vancomycin resistance. These enzymes ensure the substitution of the PG-
pentapeptide D-ala-D-ala termini into D-ala-D-lac depsipeptide, which displays a 1000 times 
lower affinity to vancomycin (30). Vancomycin resistance is inducible via the sensor 
histidine-kinase VanS and the response regulator VanR. The fitness cost of vancomycin 
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resistance in the presence of the antibiotic is high, whereas during the un-induced state, there 
is only a slight burden, possibly due to low level expression of the van genes (87). 
 
1.1.3 Virulence factors 
The success of S. aureus is not only based on its ability to adapt to the environment, but also 
on its arsenal of virulence factors, which can cause a wide range of infections (5). They are 
roughly divided into two groups: surface-associated and secreted virulence factors. The 
former mainly comprises factors, which are important during the early phases of an infection 
and promote colonization and evasion of the host immune system (160). The latter is 
important at later stages of an infection and facilitates invasion and dissemination of the 
bacteria as well as the acquisition of nutrients. The following chapter introduces a selection of 
important virulence determinants in S. aureus. 
 
1.1.3.1 Surface-associated virulence factors 
Many surface-associated virulence factors belong to the microbial surface components 
recognizing adhesive matrix molecules (MSCRAMM) and are covalently attached to the cell 
wall (50). Proteins destined for the cell wall contain a C-terminal LPXTG-motif, which is 
recognized and cleaved by the sortase A (SrtA) (165, 244, 246). Surface proteins containing a 
signal peptide with an YSIRK/GS motif are addressed to the cross wall near the division site 
and eventually across the whole cell surface, whereas proteins without the YSIRK/GS motif 
are trafficked to the cell poles (64). 
One of the key functions of the MSCRAMMs is to mediate adhesion to the extracellular 
matrix and host proteins, such as fibronectin, fibrinogen, collagen, elastin and vitronectin. 
 
Fibronectin binding proteins (FnBP) 
S. aureus has two fibronectin binding proteins A and B (FnBPAB). Depending on the region 
they share 45 to 95 % aa identity (139, 258). Both FnBPs are able to bind fibronectin, elastin 
and platelets (112, 293) and they were shown to act as invasins in endothelial, epithelial and 
fibroblast cells by binding to the integrin α5β1 host cell receptor via fibronectin (259, 260). 
The uptake of S. aureus by endothelial cells is believed to promote bacterial dissemination 
and persistence (261). Most clinical isolates harbour at least one FnBP (219). FnBPA, but not 
FnBPB, binds to fibrinogen and can induce platelet aggregation (114), thus the two proteins 
are not entirely redundant. 
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S. aureus strain Newman possesses two truncated FnBPs, that lack the LPXTG-motif due to a 
point mutation resulting in an early stop codon and are entirely secreted (100). 
 
Clumping factor (Clf) 
The two structurally similar clumping factors ClfA and ClfB belong to the serine-aspartate 
repeat (Sdr) family of covalently attached surface proteins (49, 141, 168). Both proteins are 
fibrinogen binding proteins that promote cell clumping and platelet aggregation (168, 204) 
and thereby contribute to endovascular infections (81, 182). In addition, ClfB supports 
binding to squamous epithelial cells and keratinocytes, most likely via cytokeratin 10, which 
is exposed on both cell types (205, 291). Furthermore, a human nasal colonization study 
revealed ClfB to be important for S. aureus persistence (297). 
ClfA plays a role in the host immune evasion by binding the host complement control protein, 
factor I (107). The highly potent opsonin C3b, which is also part of the complement system, 
marks S. aureus cells for phagocytosis and can be inactivated by the regulatory protein factor 
I (57). By hijacking factor I, S. aureus increases C3b cleavage and thereby decreases 
phagocytosis. In addition, binding of fibrinogen to ClfA is proposed to be necessary for factor 
I activation (106) 
 
Protein A (SpA) 
The cell wall anchored protein A (SpA), encoded by the gene spa, is particularly known for 
its immunomodulatory effects by binding with high affinity to the Fc region of 
immunoglobulin G (IgG), thereby lowering phagocytosis (85, 179, 221). Recently, it was also 
shown to bind and activate the tumor necrosis factor α (TNFα) receptor 1 (TNFR1) (97) and 
trigger T cell-independent B cell proliferation (14). Further adhesive properties are the 
binding to the von Willebrand factor (vWF), which is a large glycoprotein mediating platelet 
adhesion at sites of vascular injury (109) as well as to the platelet receptor gC1qR/p33 (192). 
The complex role of SpA has led to several studies addressing the question to what extent 
SpA contributes to the virulence of S. aureus, which is still being debated. However, SpA 
seems to play a crucial role in biofilm related subcutaneous catheter infections in mice (176) 
and a SpA-deficient strain showed decreased virulence in a murine septic arthritis model 
(215).  
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Other prominent MSCRAMMs are the collagen-binding protein (Cna), the serine-rich adhesin 
for platelets protein (SraP), the Iron-regulated surface determinant (Isd) protein family and the 
Sdr family. For more details see reviews (50, 112). 
A second group of adhesins are the secretable expanded repertoire adhesive molecules termed 
SERAM (43). The group characterizes secreted and non-covalently surface-associated 
proteins. 
 
Coagulase (Coa) 
The fibrinogen binding protein Coa is secreted into the media, however, it has also been found 
to remain partly surface-associated (23, 169). Coa promotes clotting of plasma or blood by 
binding to prothrombin and converting it non-enzymatically into its active form, thereby 
inducing polymerization of fibrinogen to fibrin (23, 89). Furthermore, Coa was shown to 
adhere to immobilized platelets probably via fibrinogen (113). A second coagulase, the von 
Willebrand factor binding protein (vWbp), also promotes fibrin coagulation by prothrombin 
activation (149). It was shown that staphylococcal binding to fibrinogen or fibrin via Coa and 
vWbp is associated with abscess formation, bacterial persistence in host tissue and the 
escaping of the host immune system (45, 46, 101). So far, no conclusive role in pathogenicity 
can be ascribed to Coa, since several studies have shown a diverse effect (8, 46, 182, 222, 
240, 266). 
 
Extracellular adhesive protein (Eap/Map/P70) 
The conserved adhesin Eap has a broad binding spectrum, which ranges from plasma and 
matrix glycoproteins to eukaryotic cell surfaces and staphylococcal cells (84, 126, 138, 171, 
212). The rebinding to S. aureus cells is ascribed to the interaction between Eap and the 
neutral phosphatase (84). Moreover, it was found to enhance internalization of S. aureus into 
fibroblasts, epithelial cells and keratinocytes (31, 105). Eap was also shown to have 
immunomodulatory/anti-inflammatory properties by binding to the intercellular adhesion 
molecule 1 receptor (ICAM-1), thereby inhibiting neutrophil binding to endothelial cells and 
decreasing endothelial transmigration of neutrophils and their extravasation (104). By 
triggering TNFα release it promotes attachment to endothelial cells via SpA and the 
gC1qR/p33 receptor on endothelial cells (79). 
 
Further well-known fibrinogen binding proteins belonging to the SERAM group are the 
extracellular fibrinogen binding protein (Efb/Fib) (213, 214), the fibrinogen binding protein A 
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(FbpA) (47) and the extracellular matrix binding protein (Emp), which displays a broad range 
of binding activity, including fibronectin, collagen and vitronectin (125). 
 
In addition, there are several non-proteinaceous virulence factors, which play a role in host 
colonization or immune evasion, such as cell wall components including teichoic acids (88, 
294, 295), capsular polysaccharides (207) and the polysaccharide intercellular adhesin (PIA) 
encoded by the icaABCD operon (206).  
 
1.1.3.2 Secreted virulence factors 
S. aureus secretes a variety of diverse virulence determinants, such as membrane damaging 
toxins, exfoliative toxins, superantigens, exoenzmyes and proteases. Probably the most 
prominent haemolytic toxin is the α-haemolysin, encoded in the hla gene. Hla is expressed in 
most strains and is a pore-forming monomeric toxin exhibiting not only haemolytic, but also 
dermonecrotic and neurotoxic properties (19, 71). The α-toxin monomer binds to the target 
cell, integrates into the cell membrane and oligomerizes to a cylindrical heptamer pore (265). 
This leads to uncontrolled ion efflux/influx and finally to rupture of the cell. β-haemolysin, 
the antagonist of Hla, is a sphingomyelinase C and hydrolyzes membrane phospholipids. Hlb 
displays a hot-cold phenotype, leading to a stronger lysis after an incubation step at 4 °C 
(262). A third haemolysin, the δ-toxin, is encoded within the RNAIII molecule of the 
accessory gene regulator (agr) regulatory system (10). Hld belongs to the amphipathic peptide 
group of phenol-soluble modulins (PSM), which have diverse functions in pathogenicity (220, 
292). Furthermore, there are the bi-component toxins, γ-haemolysin encoded by hlgABC and 
the Panton-Valentine leukocidin (PVL), encoded by lukFS. The γ-toxin is able to lyse 
erythrocytes and both toxins the γ-haemolysin and PVL affect neutrophils and macrophages. 
PVL, which was shown to be only produced by 2-3 % of the strains (150), has become more 
prominent in CA-MRSA, probably accounting for the increased virulence in those strains (69, 
95, 275). 
 
To manipulate the host immune system S. aureus possesses a number of superantigens. These 
polypeptides include several staphylococcal enterotoxins (SEA, SEB, SEC, SED, SEE and 
SEH) and the toxic shock syndrome toxin-1 (TSST-1). These exotoxins trigger excessive and 
abnormal T-cell activation by binding directly to the MHC class II molecules and the T-cell 
antigen receptor. This leads to a massive release of pro-inflammatory cytokines (TNFα and 
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interferon-γ) and further recruitment of B- and T-cells to the site of infection, which may 
eventually end in shock (159, 284). 
Additional virulence factors affecting the host immunity are the chemotaxis inhibitory protein 
(CHIPS), the staphylococcal complement inhibitory protein (SCIN) and the formyl peptide 
receptor-like 1 inhibitory protein (FLIPr). 
 
A further group of exoproteins are enzymes, which consist of proteases, lipases, 
hyaluronidases and nucleases. They are important for invasion and nutrient acquisition. 
 
1.1.3.3 Regulation of virulence factors 
It is crucial for the bacteria to coordinate the expression of the virulence factors during 
different growth phases, as well as in response to endogenous, host and environmental 
signals, such as cell density, energy availability, pH or CO2. The regulation of virulence 
factors is very complex and controlled by several two-component regulatory systems, whereof 
agr (203) belongs to the best described global regulator in S. aureus. The agr system is 
growth phase dependent and consists of two divergent transcripts containing the agrACDB 
operon and RNAIII, which are under the control of the two promoters P2 and P3, respectively 
(Figure 4) (203). The RNAIII transcript also encodes the δ-haemolysin, which does not play a 
role in regulation (131). The integral membrane protein AgrB is responsible for the 
posttranslational processing of the in agrD encoded propeptide and its secretion (134, 135). 
The autoinducing peptide (AIP) consists of seven to nine aa’s containing a pentapeptide 
thiolactone macrocycle and is recognized by the histidine kinase receptor of the membrane 
protein AgrC. Up to date there are four different agr subtypes, which express distinct AIPs, 
which vary in their aa composition (132, 134). The otherwise conserved agr locus contains a 
sequence variation spanning the section from the C-terminal region of agrB to the N-terminal 
region of agrC (Figure 4), which contains the locus for the peptide processing and ligand-
receptor interactions (134). Consequently, the different AIPs are able to bind to the receptor 
of AgrC, but only the cognate signal peptide triggers the autophosphorylation of AgrC and the 
activation of the agr response. The binding of extrinsic AIPs leads to an intra-species cross-
inhibition of agr-dependent virulence factor expression. The activated response regulator 
AgrA binds to the promoter region of P2 and P3 (147) and induces transcription of the RNAII 
and RNAIII transcripts, thereby completing the autoinduction cycle. The effector molecule 
RNAIII initiates the transcription of its target genes either directly or indirectly via other 
regulators (173, 243, 270). in vitro in the idealized batch culture, RNAIII upregulates most of 
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the secreted proteins, which are important for invasion and dissemination during the late 
exponential and stationary phase, and downregulates most of the surface proteins, which are 
central for colonization and evasion of the host immune system during the lag and early 
exponential phase (203). Since many studies were performed in vitro, the agr signalling 
during infections still remains poorly understood (48, 92, 227). 
Additional to agr, there are many other virulence regulators, such as the SarA family, SaeRS, 
ArlRS, SrrAB and SvrA (as reviewed in (201)). 
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Figure 4. Schemativ overview of the agr quorum sensing system in S. aureus. agrD encodes the propeptide, 
which is subsequently processed to AIP and secreted by AgrB. AIPs bind and activate the sensor histidine kinase 
AgrC, which activates the effector AgrA. AgrA binds to the promoter region and induces transcription of the 
agrACDB operon and the major effector RNAIII leading to a growth phase dependent expression of surface and 
secreted proteins. Adapted from (202).  
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1.2 Protein secretion – “the pathways to pathogenesis” (254) 
To fulfil their functions, the numerous virulence factors and antibiotic resistance determinants 
of S. aureus have to be transported across the membrane to their destined location, the cell 
membrane, the cell wall or the extracellular space. 
Different secretion systems have evolved and were first described in Gram-negative bacteria. 
Up to date, there are six main secretion systems in Gram-negative bacteria: type I - type VI 
(Figure 5A). Substrates from the type I, III, IV and VI secretion systems are generally 
transported in one step and substrates from the type II and V secretion systems in two, relying 
on the Sec or Tat pathway for the precedent transport into the periplasm (279). The different 
secretion systems transport various substrates across the membranes, ranging from virulence 
factors and effector proteins to nucleic acids or flagellar proteins (279). Since the 
classification was originally introduced for Gram-negative bacteria possessing a cytoplasmic 
and an outer membrane, it is unfavourable to assign the transport systems of Gram-positive 
bacteria to the different type secretion systems of Gram-negative bacteria (67). 
In Gram-positive bacteria the main pathway for protein export is the Sec secretion system. 
Other secretion or special purpose pathways are the twin-arginine (Tat) pathway, the Esx 
secretion system, ATP-bindinc cassette (ABC) transporters, the pseudopilin (Com) export 
pathway, holins and lysis (Figure 5B) (67, 254, 272). In addition, there are various assembly 
pathways, for example the pilus assembly in Bacillus cereus (29) or the flagella export 
apparatus in Listeria monocytogenes (20), which will not be further discussed (67, 245). 
The Tat and the Sec secretion systems are ubiquitous in all three major kingdoms of life, but 
only the Sec system is essential for viability (1, 216). The Sec system is responsible for the 
export of most proteins and is best described in the Gram-negative model organism E. coli (as 
reviewed in (73, 74, 161)). 
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Figure 5. A simplified overview of bacterial secretion systems. Several different transport systems have 
evolved in microorganisms. (A) Type I - VI secretion systems in Gram-negative bacteria. (B) Secretion systems 
in Gram-positive bacteria. HM, host membrane; OM, outer membrane; IM, inner membrane; OMP, outer 
membrane protein; MFP; membrane fusion protein; ATPases and chaperones are shown in yellow; Esx, Esat-6 
secretion system or WXG100 secretion system; Com, pseudopilin export pathway. Adapted and modified from 
(279). 
 
Overview of the Sec pathway in E. coli 
The Sec machinery consists of the protein conducting channel SecYEG with a single SecY 
molecule as the actual channel protein, which is clamped together by the SecE subunit (15, 
217). The hourglass-like hydrophilic pore is blocked by a helix plug from the exterior, which 
is displaced for polypeptide translocation (15, 28). The exact function of SecG is still 
unknown, it is not essential for protein export or cell viability, but was shown to enhance 
translocation efficiency in vitro (108, 197, 198). SecG undergoes topology inversions coupled 
with the cycling of multiple molecules of SecA (183, 189, 199, 267). The motor protein SecA 
is involved in targeting of the preproteins to the translocase and is able to bind with high 
affinity to the SecYEG and with low affinity to acidic phospholipids (116). The 
conformational changes of SecA induced by binding and hydrolysis of ATP promotes protein 
translocation and is stabilized by the accessory complex SecDF-YajC (77, 78). Recently it 
was shown, that SecA alone is sufficient for translocation and ion channel activity in 
liposomes, but requires SecYEG and SecDF-YajC for specific and efficient transportation 
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(123, 124). The auxiliary membrane protein SecDF, which belongs to the resistance-
nodulation-cell division (RND) family, forms a heterotrimeric complex with YajC and was 
shown to associate with SecYEG and YidC (76, 200), possibly as the linking molecule during 
Sec-dependent insertion of membrane proteins. It was furthermore shown that SecDF 
enhances protein translocation by binding to the preproteins and preventing backsliding by 
conformational changes of the head domain P1 (282). This last step is driven by the proton 
motive force (PMF) and is ATP-independent. YajC, which function is still unknown, was 
found to co-crystallize with the well known multidrug exporter AcrB (225, 269, 274). 
Proteins containing an N-terminal signal peptide (SP) or a hydrophobic transmembrane (TM) 
domain are targeted to the translocase with the help of chaperones, which also prevent 
premature folding of the preproteins (41). There are two major targeting routes to the Sec 
translocase: The co- and the post-translational route (Figure 6) (74). The post-translational 
export is mainly used by secretory proteins, which together with membrane proteins 
containing large hydrophilic loops use the SecA cycling as driving energy (Figure 6A). 
Membrane proteins are mainly targeted as ribosome-bound nascent chain by the signal 
recognition particle (SRP, Figure 6B) and transported to the membrane receptor FtsY (153, 
283). Upon GTP hydrolysis the ribosome-bound nascent chain is transferred to the translocon 
and co-translationally exported powered by the translating ribosome. Furthermore, small 
membrane proteins can be inserted Sec-independently by YidC (200) (Figure 6C). The signal 
sequence is cleaved off by the SPase I (59) and the preprotein is folded into its mature form 
with the help of different chaperones (2) or transported for further trafficking. 
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Figure 6. Schematic overview of the Sec pathway in E. coli with its different targeting routes. (A) Secretory 
preproteins are mainly post-translationally directed to the SecYEG translocation channel by SecB, a molecular 
chaperone, which is only found in Gram-negatives. The signal sequence is cleaved off by the signal peptidase 
(dark grey) at the outer side of the membrane. (B) Membrane proteins and some preproteins are co-
translationally targeted as ribosome-bound nascent chain to the protein conducting channel by the SRP (pink). 
The SRP interacts with the N-terminal signal sequence or the hydrophobic TM segment of the nascent peptide. 
(C) Some membrane proteins are inserted into the membrane independently of the Sec system by YidC (dark 
yellow). Taken from (74). 
 
The Sec pathway in S. aureus 
Data on the Sec system in S. aureus is scarce. In different screens for essential genes secY was 
shown to be essential, whereas the results for secDF, secE and secA were ambiguous (9, 42, 
86, 136). A secG deletion mutant showed an altered exoproteome, which was exacerbated in a 
secG secY2 double mutant (253), however, the secY2 single mutant did not show any effects 
on protein secretion. secY2 together with secA2 belong to the accessory Sec system, which is 
responsible for the export of the serine-rich adhesin for platelets protein (SraP) (255). The 
different sec mutants; secG, secY2 and the double mutant secG secY2, had no effect on 
virulence in a mouse infection model (253). 
SecDF was identified in a proteomic approach of membrane vesicles (155). Furthermore, its 
expression was slightly higher in a COL sigB deletion mutant (115). 
 
 
 
 
  Introduction 
  19 
Other secretion pathways in S. aureus 
In addition to the general Sec pathway, S. aureus possesses more specified or special purpose 
secretion systems, which are responsible for the transport of a small number of proteins. The 
following section gives an overview of pathways found in S. aureus. 
 
The Tat system in S. aureus is composed of the minimal translocase TatA and TatC (301). In 
contrast to the Sec system, Tat-dependent proteins are translocated in a fully folded form (18). 
So far, only the iron-dependent peroxidase FepB was found to have a typical twin-arginine 
(RR) signal peptide and to be exported by the Tat pathway (22). TatAC of S. aureus 
expressed in B. subtilis was shown to be intrinsically salt-sensitive (287). 
 
Another transport system is the Esx system, which is also called the Esat-6, the WXG100 or 
the type VII secretion system following the secretion system nomenclature of Gram-negative 
bacteria (67). Esx is unique to Gram-positive bacteria and was first identified in 
Mycobacterium tuberculosis (70). In S. aureus, the Esx system is composed of a cluster with 
at least eight genes. The size of its target-proteins is approximately 100 residues and they 
exhibit a conserved Trp-X-Gly motif (WXG100 family proteins) (211). To date, the 
staphylococcal proteins EsxA, EsxB and the non-WXG100 motif protein EsaC were shown to 
be transported by the Esx system and the proteins EssABC and EsaD to be important for 
secretion (4, 32, 33, 44). The role of the secreted proteins EsxAB and EsaC is still unclear, but 
they were shown to play a role in S. aureus persistence and murine abscess formation (32, 
33). The crystal structure of the integral membrane protein EssB was recently characterized 
and revealed a dimeric formation with a similar structure as serine/threonine protein kinases 
(303).  
 
The Com pathway is involved in DNA binding and uptake and plays a role in natural 
competence in B. subtilis (75). In S. aureus, the pseudopilin pathway is partly represented 
with the four proteins ComC, ComGA, ComGB and GomGC (missing ComGD, ComGE and 
ComGG) (254). ComGC was shown to localize to the membrane, the cell wall and the cell 
surface (286). The biogenesis of ComGC relies on the stabilization activities of the thiol-
disulfide oxidoreductase DsbA, as well as the cleavage by the signal peptidase ComC into its 
mature form. The precise role of the Com pathway in S. aureus is still unclear. 
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ABC transporters are composed of two transmembrane domains and two cytoplasmic 
nucleotide-binding domains with ATPase activity (61). in silico screening of the 
staphylococcal genome has identified numerous putative ABC transporters (209). They are 
involved in the secretion or uptake of a variety of molecules and exhibit diverse functions, 
which range from: (i) antibiotic resistance by serving as efflux pumps as proposed for the 
plasmid-encoded vgaB, which confers resistance to streptogramin A (3); (ii) the uptake of 
essential solutes, as suggested for the siderophore-dependent iron acquisition by SirABC (58) 
or (iii) the export of bacteriocins (209). 
Recently, a novel ABC transporter Pmt was identified in S. aureus. Pmt is encoded by the 
pmtABCD operon and was shown to be essential for the export of phenol-soluble modulins 
(PSMs) (40). PSMs, which include the δ-haemolysin, are peptide toxins and exhibit diverse 
functions in S. aureus pathogenesis (220). 
 
Finally, there are the two export systems: holins, which are involved in the export of PG-
degrading enzymes as proposed for the CidA and LrgA proteins (228) and natural cell lysis. 
 
1.3 RND proteins 
The resistance-nodulation-cell division (RND) family belongs to the multidrug resistance 
(MDR) efflux pumps. RND proteins are characterized by a typical structure of twelve TM 
domains with two extracytoplasmic loops between the TM1-2 and the TM7-8 revealing two 
repeats, which are thought to arise from internal gene duplication (Figure 7A) (239, 278). As 
an energy source they use the PMF. RNDs are found throughout all three domains of life 
(archeae, bacteria and eukaryotes) (278) and have been ascribed diverse functions, ranging 
from the export of virulence factors, including quorum sensing signals (223) to the 
morphogen receptor Ptc, which plays a role in Drosophila melanogaster development (137, 
278). Two prominent representatives are; SecDF, an accessory component of the Sec 
secretion system and the well-studied acriflavine resistance protein B (AcrB) from E. coli. 
 
AcrB together with the outer membrane protein TolC and the membrane fusion protein AcrA 
form the tripartite efflux system AcrAB-TolC (Figure 7B) (186). AcrA acts as a linker 
between AcrB and TolC as depicted in Figure 7C. The constitutively active RND pump is 
responsible for the efflux of a broad range of substrates, such as lipophilic antibiotics, dyes, 
detergents and host-derived substances, like bile salts (162, 193, 195, 196, 271). Substrate 
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specificity is determined by the periplasmic loops of AcrB (80) and it is assumed that the 
substrates are exclusively captured from the periplasm or the periplasm-inner membrane 
interface (193, 194). The driving energy for the drug pumping is from the proton motive force 
through the AcrB transmembrane domain (186, 250). Since bacterial multidrug efflux pumps 
reduce drug accumulation in the cell, they are often associated with antibiotic resistance 
(193). 
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Figure 7. Models of RND proteins and the multidrug exporter AcrAB-TolC. (A) Topology model of a 
typical RND protein with twelve TM domains with two large hydrophilic loops. Taken from (127). (B) Side 
view of the trimeric RND protein AcrB of E. coli with its different domains. Taken from (249) (C) Schematic 
picture based on X-ray structures of AcrAB-TolC with the drug/proton flow. Modified from (249). 
 
One eukaryotic AcrB homologue is the human RND protein Niemann-Pick C1 (NCP1). 
NCP1 can bind cholesterol and plays a crucial role in intracellular cholesterol trafficking, 
although its precise function still remains debated (60, 143, 278). The NCP1 disease leads to a 
lipid storage disorder, the accumulation of intracellular cholesterol and cell death. In 95 % of 
the cases, it is caused by mutations in the aa sequence of NCP1. NCP1 expressed in E. coli 
facilitated the import of acriflavine and oleic acid, but not cholesterol, revealing a transport 
function (60). 
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M. tuberculosis possesses several proteins described as mycobacterial membrane protein large 
(MmpL) belonging to the RND family. MmpL genes are often found in clusters involved in 
the biosynthesis of cell wall-associated glycolipids, which can make up to 60 % of the 
mycobacterial cell wall (268). Lipid transport functions have been described for MmpL7, 
MmpL8 and the essential protein MmpL3 (52, 130, 289). 
So far, only one out of the 13 MmpL proteins was shown to play a role in antibiotic 
resistance. Over-expression of MmpL7 in Mycobacterium smegmatis leads to resistance 
towards isoniazid, a first-line antibiotic for treatment of tuberculosis (218, 232). Furthermore, 
MmpL7 is involved in phthiocerol dimycocerosate (PDIM) transport across the cell 
membrane (130). PDIM is a surface-exposed polyketide lipid and plays a major role in 
virulence by interacting with host cells (121, 130). Deletion of MmpL7 leads to impaired 
growth kinetics and lethality in a murine tuberculosis model (72).  
 
So far, not much is known about RND proteins in low-G+C Gram-positive bacteria. 
B. subtilis has four RND proteins: YerP, YdfJ, YdgH and SecDF. YerP is involved in self-
resistance to the cyclic lipopeptide surfactin and participates in the export of acriflavine and 
ethidium bromide (281). The second RND protein YdfJ is regulated by the TCS YdfHI. YdfJ 
contains a sterol sensing domain (252) and together with the membrane protein YdgH belongs 
to the MmpL family. The fourth RND protein is the auxiliary SecDF protein from the Sec 
secretion system. In contrast to E. coli, SecDF in B. subtilis is fused to one polypeptide. 
Deletion of secDF in B. subtilis leads to a cold-sensitive phenotype, which is aggravated 
when secretory proteins are over-expressed (24).  
 
RND proteins in S. aureus 
S. aureus has three uncharacterized proteins belonging to the RND family (Figure 8): (i) 
SecDF (SA1463) with 53 % aa identity compared to B. subtilis SecDF (ii) SA2056, a 
homologue of B. subtilis YerP with 46 % aa identity and (iii) SA2339, which has 46 % aa 
identity to YdfJ of B. subtilis and 31 % aa identity to MmpL7 of M. tuberculosis. 
 
Similar as in B. subtilis, S. aureus SecDF is encoded by a monocistronic mRNA, but the 
genetic context of secDF resembles the one of E. coli with yajC lying downstream of secDF 
(Figure 8A). Two conserved charged residues Asp519 and Arg247 were shown to be crucial 
for SecDF activity in E. coli and point mutations of the counterparts in T. thermophilus 
Asp340Asn and Arg671Met were shown to abolish ion channel activity. These conserved aa 
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are also found in the S. aureus SecDF and correspond to Asp327 and Arg679. recJ, a 
predicted single-stranded DNA-specific 5’-3’ exonuclease is situated upstream of secDF.  
 
The second S. aureus rnd gene, sa2056, lies downstream of the prominent non-ribosomal 
peptidyltransferase femX (Figure 8B), which catalyzes the addition of the first glycine to the 
pentaglycine bridge of the PG precursor. Previously, attempted knock-out experiments by 
colleagues failed (233), suggesting SA2056 to be important for viability. Knock-down 
experiments did not show any apparent phenotype and over-expression of SA2056 did not 
lead to a higher resistance against antibiotics (233). The gene lying downstream of sa2056, 
sa2055 encodes a hypothetical protein with unknown function. 
 
SA2339, the third S. aureus RND protein, is a member of the MmpL family. sa2339 was 
shown to be highly induced in a transcriptional-profiling assay, when cells were treated with 
tea tree oil (55). Tea tree oil is known to exhibit broad-spectrum antimicrobial activity in vitro 
(35). Furthermore, microarray analysis showed sa2339 to be positively affected directly or 
indirectly by the transcriptional regulator NorG (276). NorG was shown to bind to promoters 
of several multidrug efflux pumps encoding genes and to modulate resistance to quinolones 
and β-lactams (277). sa2340, which is situated upstream of sa2339, contains a helix-turn-
helix (HTH) TetR-type DNA binding domain and is therefore categorized into to the 
transcriptional regulator TetR-family (Figure 8C). sa2338 lying downstream of sa2339 
contains a FeoA domain (Fe2+ transport system protein A). 
 
sa2055
femX
sa2338
sa2340
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yajC
sa2056
sa2339
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C
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Figure 8. Genetic organization of secDF, sa2056 and sa2339 in S. aureus including predicted promoter and 
Rho-independent transcription terminators. (A) secDF locus (2.28 kb) (B) sa2056 locus (3.168 kb) and (C) 
sa2339 locus (2.49 kb) of S. aureus N315. Genes encoding proteins belonging to the RND family are coloured in 
yellow. Promoter (263) and terminator (264) predictions are depicted by arrows and hairpins, respectively. 
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2 Aims of this study 
The RND proteins were first thought to be exclusive in Gram-negative bacteria (239). 
However, a phylogenetic analysis by Tseng et al. revealed RNDs to be ubiquitous and present 
in all three major kingdoms of life (278). So far, most studies of the RND proteins were 
performed in Gram-negative bacteria or M. tuberculosis and information on RNDs in low-
G+C Gram-positive bacteria is scarce. Their diverse functions and in particular their 
contribution to antibiotic resistance by multidrug efflux transporters, make them an interesting 
target. 
The aim of this study was to characterize the three RND proteins in the Gram-positive 
bacterium S. aureus and especially to elucidate their role in fitness, resistance and virulence. 
This was achieved by the construction of three S. aureus RND single mutants using a new 
markerless deletion system. A thorough phenotype analysis was performed, consisting of 
growth and fitness studies under different stress conditions and a resistance profile analysis 
for several antibiotics, RND substrates and fatty acids. 
 
Project I Analysis of the AcrB homologue SA2056 
Due to the conserved genetic organization of femX-sa2056 in S. aureus and the weak co-
transcription of sa2056 with femX, a role of SA2056 in cell wall biosynthesis seemed possible 
(233). In parallel to studies concerning the topology and identification of interaction partners, 
transcription and expression of SA2056 during growth were determined. To assess wether 
SA2056 plays a role in cell wall synthesis, the impact of sa2056 deletion on the ultrastructure 
of the cell and autolysis was studied. Furthermore, the localization of SA2056-GFP 
recombinant proteins was analyzed to reveal its position during cell separation.  
 
Project II Determination of SecDF in S. aureus resistance and expression of 
virulence factors 
To elucidate the influence of SecDF on β-lactam resistance and the export of RND substrates 
in S. aureus, the secDF mutant was further analysed regarding the expression and 
transcription of several well known and Sec-dependent virulence factors. Cell morphology, 
autolytic activity and the expression of PBPs were studied. 
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Project III Defining the role of SecDF in S. aureus virulence 
For examining the effect of protein secretion, a quantitative secretome analysis was 
performed. Follow up experiments comprised confirmation and complementation by Western 
blot and the verification in a second strain background. Consequences of the altered 
exoproteome for virulence of the secDF mutant was assessed by in vitro assays with human 
umbilical vein endothelial cells and an in vivo infection assay in a Galleria mellonella insect 
model.  
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3 Results 
3.1 Project I 
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3.2 Project II 
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3.3 Project III 
 
Manuscript accepted and pusblished in PLoS ONE: Quiblier C, et al. (2013) Secretome analysis defines the 
major role of SecDF in Staphylococcus aureus virulence. PLoS ONE 8: e63513 EP  -. 
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4 Comments and Outlook 
The ubiquitous RND superfamily has diverse biological functions, ranging from sterol 
homeostasis and multidrug export to the morphogen receptor Ptc, which plays a role in 
Drosophila melanogaster development (137, 278). This is the first comprehensive study of 
the three RND proteins SecDF, SA2056 and SA2339 in the Gram-positive bacterium 
S. aureus.  
In E. coli, SecDF is postulated to be an accessory protein of the Sec machinery enhancing 
protein export, in particular at late stages of protein secretion. Deletion of secDF in S. aureus 
caused a very complex phenotype, affecting even Sec-independent proteins. As expected, 
protein secretion was not entirely interrupted when SecDF was missing in S. aureus, but the 
majority of Sec-dependent virulence factors were in some way affected, leading to a 
decreased virulence in an insect animal model. Considering that SecDF shows a high potential 
as a target for antimicrobial substances, a next crucial step would be to confirm the 
importance of SecDF for virulence in a murine infection model and screening for inhibitors of 
SecDF. 
Since membrane proteins are also targeted to the Sec machinery, the insertion of important 
TCS sensor histidine-kinases into the membrane could be disturbed by the absence of SecDF, 
leading to an inefficient signalling system as was indicated by the slightly reduced 
transcription of agr. This could be further analyzed by quantitative proteomics of the 
membrane subcellular fractions and by transcription and expression analysis of major TCS. 
Depending on the microorganism different localization patterns were found for the Sec 
machinery. In B. subtilis, SecA and SecY were shown to localize in clusters that were 
organized in a spiral-like structure across the cell (34). In contrast, SecA of Streptococcus 
pyogenes was restricted to one discrete patch called the ExPortal (235, 236). This Sec 
translocase containing microdomain is in remote distance from both cell poles and is 
proposed to serve as a compartment for posttranslocational protein folding. No SecDF 
homologue was found in S. pyogenes, nevertheless, it would be relevant to see where SecDF 
localizes in S. aureus; over the entire cell membrane or in distinct patches. 
Another gene of interest is yajC lying downstream of secDF. In E. coli, yajC is co-transcribed 
with secD and secF (225). Furthermore, YajC forms a heterotrimeric complex with SecDF 
and was found to interact with AcrB (274). However, the function of YajC is still unknown. 
Northern blot analysis in S. aureus revealed yajC to be transcribed alone and with the 
downstream lying gene tgt encoding a queuine tRNA-ribosyltransferase, but not with secDF 
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(unpublished data). This is in accordance with the predicted promoters upstream of yajC and 
tgt, and with a Rho-independent terminator situated between yajC and secDF. A yajC single 
and a yajC-secDF double mutant could provide more insights into a possible role of YajC in 
the Sec pathway. Another interesting aspect would be the identification of SecDF interaction 
partners in S. aureus and to verify the interaction partners found for E. coli SecDF (YajC, 
SecYEG and YidC) with the S. aureus SecDF.  
The roles of SA2056 and the MmpL-like protein SA2339 still have to be elucidated, as for 
both mutants no major phenotype was obtained under the conditions tested. The strain 
background can play a crucial role for studying gene function, as reported for the expression 
of the extracytoplasmic-function σ-factor (ECF) σS, which was shown to be differently 
expressed depending on the strain (177). Hence, it should be reconsidered to construct the rnd 
knock-out mutants in other strain backgrounds. In addition, functional redundancy of the 
S. aureus RND proteins should be excluded by constructing RND double mutants and a RND 
triple mutant containing the inducible rnd genes in trans. 
SA2056 and SA2339 seem to have very high substrate specificity as testing several different 
compounds did not reveal any effects; further screening of possible allocrites (compounds to 
be transported) or interaction partners could be helpful to determine their role in S. aureus.  
Phenotype analysis of sa2056 and sa2339 are primarily based on in vitro assays, hence it 
would be of major interest to analyse their relevance in vivo. To keep animal models to a 
minimum, this could first be performed in a whole blood killing assay and by using an 
invertebrate infection model. 
The interaction of SA2056 with FemB and other proteins involved in PG synthesis indicates 
an auxiliary role of SA2056 in cell wall synthesis. SA2056 was also shown to interact with 
itself suggesting formation of a trimer as shown for the multidrug efflux pump AcrB in E. coli 
(186). Thus, determining the crystal structure of SA2056 might reveal more clues regarding 
its purpose. 
Genome sequencing of an in vitro generated ceftobiprole resistant mecA-negative strain COL 
revealed five single-nucleotide polymorphisms (SNPs) in three different genes; the 
carboxypeptidase pbp4, the cyclic-di-AMP phosphodiesterase gdpP and sa2056 (11). 
Ceftobiprole is a 5th generation cephalosporin with binding activity against all PBPs including 
PBP2a (145). Interestingly, PBP4 and GdpP both directly or indirectly have an influence on 
the cross-linking of PG and β-lactam resistance (99, 117, 156, 175, 226, 256), further 
supporting the hypothesis of SA2056 playing a role in cell wall synthesis. Preliminary tests 
showed that the sa2056 mutant in an MRSA background was only slightly more susceptible 
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towards ceftobiprole than the wild type (unpublished data). These results are in need of 
complementation and further investigations. A possible indicator for a disturbed cell wall 
biosynthesis is increased basal expression of the cell wall stress stimulon (CWSS) (140, 151, 
285). The CWSS is activated by the autoregulated TCS VraSR and can be measured by a 
promoter-luciferase fusion of the promoter of the vraSR-operon (66). Initial tests showed a 
slightly increased CWSS for the secDF mutant (unpublished data), which is in accordance 
with the aberrant cell separation. CWSS examinations will be extended for the sa2056 and the 
sa2339 mutant. 
In this study three S. aureus RND proteins were analyzed and two, SA2056 and SecDF were 
characterized in more detail. The importance of this protein family was shown by the deletion 
of secDF revealing a major impact on resistance to well-known antibiotics and on S. aureus 
virulence. Thus, it is of great value to gain more knowledge of the different functions of these 
transporter proteins and to find their possible substrates. 
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